Time's Up For Sundial Herbs – US Firm Recalls All Products Seven Years After FDA’s Warning
FDA officials, following each Sundial Herbs response since 2013 to the agency stating that it had corrected problems identified during inspections, found continued violations on the firm’s website and in its store. Investigators purchased the firm’s products with violative claims as recently as February.
You may also be interested in...
Warning letters noting the coronavirus have slowed to a drip in the US while recalls continue climbing for products already identified in warnings.
In Brief: revised NDI draft expected in 2013, MusclePharm invests, Sundial label and GMP warnings, AHPA publishes organic guidance
CFSAN plans revised NDI draft in 2013; MusclePharm invests in BioZone delivery tech; Indiana kicks off anti-smurfing campaign; Sundial fails basic labeling, GMP compliance; AHPA advises supplement firms on organic rules; Naturex commits to sustainability; Targeted Medical Pharma expands into supplements.
Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected.